2026 Exhibitor Profiles

Connecting You with the Industry’s Top Innovators & Suppliers

View the Floor Plan

  • Aarti Pharmalabs Limited is a small molecule drug substance CDMO offering clinical and commercial CMC services including Process Research, Development and Manufacturing of GMP APIs, NCEs, RSMs, and Intermediates. We have been supporting customers worldwide by developing the most efficient processes to meet their clinical and commercial phase requirements.

  • Vision. Expertise. Success.

    AbbVie Contract Manufacturing partners with companies across the globe to develop, scale and manufacture pharmaceutical products and bring them successfully to market.

  • Acutaas Chemicals Limited is a leading manufacturer of pharmaceutical intermediates, fine chemicals, and specialty compounds. With a focus on innovation and quality, we deliver tailored chemical solutions to global pharmaceutical partners.

  • Adesis is a U.S.-based CRO/CDMO specializing in custom chemistry, process development, and early-phase API manufacturing for small molecule programs. The company supports biotech and pharma partners from discovery through IND-enabling development, with capabilities in route scouting, medicinal chemistry, scale-up, and cGMP production.

  • Agno Pharma is a global pharmaceutical contract research and manufacturing organization (CRO & CMO). Agno Pharma engages in the research, development, manufacturing, sourcing, marketing, and distribution of pharmaceutical intermediates, APIs, nutraceuticals, and fine chemicals.

  • Apeloa Pharma Solutions is the global CDMO business unit of Apeloa Pharmaceutical Co. Ltd., offering fully integrated services across the pharmaceutical value chain including R&D, custom synthesis, API manufacturing, and drug product development. With a strong global presence, Apeloa serves both innovator and generic pharmaceutical companies worldwide.

  • Apollo Scientific is a global supplier and manufacturer of high-quality research chemicals, advanced intermediates, and life science reagents supporting pharmaceutical & biotech. The company offers a broad catalogue alongside custom synthesis, route scouting, and sourcing services, with particular strength in fluorochemicals, heterocycles, boronic acids, and complex organic building blocks.

  • AQ BioPharma specializes in fluorinated pharmaceutical intermediates, fluorinated building blocks, and specialty heterocyclic compounds for pharmaceutical R&D and manufacturing. Founded in 2007, the company supports drug discovery and development programs through custom synthesis, process development, R&D/pilot production, and gram-to-kilogram supply. Its capabilities include route design, scale-up, impurity research, and the preparation of advanced intermediates for medicinal chemistry and process development programs.

  • Asha’s vision is to bring hope in the lives of patients, by enhancing the bioavailability of new drugs, helping them get to the market faster and reducing drug development costs. We work with our clients through the solid form screening and selection process and develop optimized crystallization processes.

  • Aurigene Pharmaceutical Services is a leading contract research, development, and manufacturing organization (CDMO). Built on the legacy of accelerating innovation and backed by vast experience in drug discovery and development, our mission is to relentlessly work for the success of our clients and to build long-term relationships through a holistic approach to accelerate the journey of a molecule from laboratory to market.

  • BirdoTech is a cutting-edge CRDMO service organization specializing in small molecule modality. Our vision is to help our clients realize maximum value, through our world-class innovation-driven drug discovery and manufacturing service platform.

  • Boron Molecular is a specialty chemical and CDMO partner focused on complex organic synthesis, including boronic acids, advanced building blocks, and small molecule APIs. Unlocking scalable innovation through deep chemistry expertise.

  • CARBOGEN AMCIS is a global CDMO providing integrated drug substance and drug product services, with particular strength in small molecule API development, highly potent compounds (HPAPI), and complex chemistries. They support programs from early development through commercial manufacturing, offering process development, scale-up, and GMP production alongside sterile fill-finish for injectable drug products.

  • CatScI Ltd specialises in the rational development and optimisation of catalysed reactions and complex chemical processes, offering unique expertise in: reaction understanding; homogeneous and heterogeneous catalysis; biocatalysis; solvent selection; process development; metal removal, recovery and recycle; training and consultancy; and analytical services…

  • Headquartered in Ann Arbor, Michigan, Cayman Chemical Company and its wholly owned subsidiary Cayman Pharma are your trusted API partners. Cayman performs CGMP manufacturing for clients worldwide for use in human and veterinary medicine. We have over 40 years of experience in developing and manufacturing APIs and have extensive proficiencies in performing multi-step organic syntheses for complex molecules. Our CGMP facilities have a proven track record of strict adherence to regulatory guidelines and requirements, and they are routinely audited by government, pharmaceutical, and independent third parties.

  • Chemspec-API provides a comprehensive service for the development and cGMP manufacture of APIs and pharmaceutical intermediates. Seamless access to resources at our parent company, Shanghai Chemspec, allows clients to optimize costs while US quality and reliability of supply are maintained.

  • Chiral Quest is a US-based company founded in 2000 and Jiangxi Long Life was founded in 2009 near Nanchang, China. In May 2012, Chiral Quest and Long Life merged to form a single company. Chiral Quest Suzhou focuses on R&D and pilot plant operations, while Chiral Quest Long Life focuses on commercial scale manufacture…

  • Cohance Lifesciences is a fast-growing, India-based pharmaceutical company focused on the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals. With a strong presence across regulated and emerging markets, Cohance supports global pharmaceutical supply chains through high-quality, scalable solutions.

  • CordenPharma is your One Partner CDMO for the global supply of APIs, Lipid Excipients, Drug Products and Packaging. Through a network of fully-inspected cGMP facilities across Europe and the US organized under six technology platforms – Peptides – Lipids & Carbohydrates – Injectables – Highly Potent & Oncology – Small Molecules – Oligonucleotides…

  • Corealis Pharma is a CDMO specializing in oral solid dosage (OSD) formulation development and early-phase clinical supply manufacturing for pharmaceutical and biotech companies. The company provides end-to-end services including API characterization, preformulation, formulation and process development, analytical method development, and cGMP clinical manufacturing and packaging.

  • CPC Scientific is a leading global CDMO specializing in the manufacture of peptides, peptide conjugates, and oligonucleotides for pharmaceutical and biotechnology companies. The company supports projects from early research through commercial production with a focus on quality, innovation, and regulatory compliance.

  • Established in 2001, Drug Discovery Alliances, Inc., is a US-based pharmaceutical consultancy specializing in small molecule R&D alliances. Our platform, backed by scientists and vetted suppliers, helps clients navigate challenges from discovery to commercialization.

  • Dipharma is a global CDMO specializing in the development, scale-up, and cGMP manufacturing of APIs and advanced intermediates for the generic and innovative pharmaceutical markets. With over 70 years of experience, we combine deep scientific expertise with flexible manufacturing capabilities across three EU-GMP certified sites.

  • DOTTIKON EXCLUSIVE SYNTHESIS is specialized on hazardous chemistry, with a focus on strongly exothermic reactions as well as unstable, highly reactive, or high-potent compounds or mixtures.

  • Element Materials Technology’s life sciences capabilities include pharmaceutical testing, GMP lot release support, raw material and excipient testing, extractables and leachables, chemical characterization, contamination and particulate analysis, compendial testing, sterility and mycoplasma testing, and medical device/material sciences testing.

  • Eurofins CDMO Alphora Inc. provides integrated outsourcing solutions for small molecules, drug product, biologics and phytocannabinoids. Specializing in complex and niche small molecule drug substance and drug product services, including high potent capabilities, we provide support from preclinical to commercial development & manufacturing.

  • ESTEVE CDMO is a global contract development and manufacturing partner specializing in small-molecule APIs, high-potency APIs, and advanced pharmaceutical intermediates. With more than 60 years of development and manufacturing experience, the company supports pharma and biotech innovators from early development through commercial supply, offering process R&D, scale-up, analytical and stability testing, cGMP API manufacturing, and CMC support.

  • Evonik Industries offers a full range of custom API manufacturing services as well as oral and parenteral formulation development expertise. Our global manufacturing footprint and technical expertise provides unique flexibility and problem-solving capabilities to meet your most demanding project’s requirements.

  • Farmhispania Group offers custom process development and custom manufacturing services for APIs, advanced intermediates and building blocks for the pharmaceutical, biopharmaceutical and related industries.

  • Fabbrica Italiana Sintetici S.p.A. is a leading Italian manufacturer of small molecule APIs, specializing in complex, high-value active ingredients for both branded and generic markets.

  • Fermion: Trusted Partner in Drug Substance Development and Manufacturing

    Fermion, a wholly owned subsidiary of Orion Corporation, specializes in the development, manufacturing, and global supply of active pharmaceutical ingredients (APIs). Headquartered in Espoo, Finland, Fermion serves both the generic pharmaceutical market and innovator companies through exclusive contracts focused on new chemical entities (NCEs).

  • GfM is the largest family-owned independent CDMO specializing in cGMP micronization and milling services for the pharmaceutical and chemical industries. Since 1985, we have served customers worldwide with a commitment to 100% quality. In 2026, we will introduce our innovative solutions to the U.S. market.

  • GlycoSyn is a world-leader in carbohydrate, polymer, pharmaceutical excipient, and complex chemistry. We can help you as a contract development and manufacturing organization (CDMO) or contract research organization (CRO).

  • Grace’s Fine Chemical Manufacturing Services (FCMS) is a North American contract development and manufacturing organization (CDMO) with decades of experience partnering with biotechs and pharma companies to solve complex chemistry challenges and seamlessly scale your project, from early development through commercial manufacturing and every phase in between.

  • Hande Sciences is a small molecule-focused Contract Development and Manufacturing Organization (CDMO) specializing in process research, process development, and both GMP and non-GMP manufacturing. With deep expertise in synthetic chemistry and flow chemistry, we partner with pharmaceutical and biotechnology companies to deliver efficient, scalable, and high-quality solutions from early development through commercial manufacturing.

    Visit Website

  • Headquartered in Milan (Italy), Indena is the leading company dedicated to the identification, development and production of high quality active principles for use in the pharmaceutical industry. Backed up by a century of experience, 4 production sites and over 1000 high-skilled staff, the company invested a significant amount of its annual turnover in research and technological expansions, making CDMO activities the key to its success and a priority in Indena’s strategic vision.

  • Jiuzhou Pharma provides customers worldwide with quality one-stop CDMO services, from preclinical chemical manufacturing and control through phase III clinical trials and new drug applications (NDA) to global marketing.

  • Jubilant Ingrevia offers a range of specialty chemical intermediates & manufactures small molecules. With over 40 years of experience in synthetic and organic chemistry, we are a key partner to the top 10 innovators in the pharmaceutical and biotech industries. Our USFDA-approved cGMP plant is available to provide custom small molecules from gram to multi-metric ton scales.

  • JYMed Peptide is a leading global CDMO specializing in the development and manufacturing of peptides and peptide-based pharmaceuticals. With fully integrated capabilities spanning R&D, GMP production, and regulatory support, JYMed serves both innovators and generics in clinical and commercial markets.

  • Kingchem is a diversified and vertically-integrated CMO offering wide-ranging manufacturing capabilities and industry-leading R&D services to customers around the globe in the Pharmaceutical, Electronic, Fine and Specialty Chemical industries.

  • Kinsy is a European CDMO specializing in the development and manufacturing of custom intermediates and APIs, with deep expertise in complex chemistry. The company is known for its ability to handle challenging syntheses, and operates under strict regulatory standards and provides tailored solutions from early-stage development to commercial production.

  • Latitude Pharmaceuticals is a formulation-focused CDMO specializing in solving complex drug delivery and bioavailability challenges, particularly for poorly soluble and difficult-to-develop compounds. The company supports programs from early formulation development through GLP/GMP manufacturing and clinical supply, with deep expertise in complex injectables, nanoformulations, and controlled-release systems.

  • Laurus Labs is a global pharmaceutical company and CDMO with a strong foundation in small molecule API manufacturing, combined with vertically integrated capabilities across drug substance and drug product. Known historically for large-scale generic API supply—particularly in antivirals and oncology—the company has expanded into contract development and manufacturing, supporting innovators from clinical development through commercial production.

  • Laxai Life Sciences is an India-based CRDMO focused on early-stage drug discovery through process development and API manufacturing, with particular strength in complex small molecule chemistry. The company supports biotech and pharma partners from hit-to-lead and lead optimization through IND-enabling work, and into scale-up and GMP manufacturing.

  • Lee Fine Chem is a pharmaceutical R&D and CDMO services company supporting the development and manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. The company provides chemistry-driven solutions for pharmaceutical partners requiring process development, scale-up, and reliable manufacturing support.

  • Lupin Manufacturing Solutions is the CDMO division of Lupin Limited, offering end-to-end manufacturing services for small molecules across APIs and finished dosage forms. With a global presence and decades of pharmaceutical expertise, Lupin serves leading innovators with reliable, scalable, and regulatory-compliant solutions.

  • Minakem is a European CDMO specializing in the development and manufacturing of small molecule active pharmaceutical ingredients (APIs) and advanced intermediates. The company supports programs from early-stage process development through commercial production, with particular strength in complex chemistry, multi-step synthesis, and high-value compounds.

  • MRIGlobal offers CDMO and CMC support services in synthesis, analytical testing, stability, and logistical support for clinical trial materials. We provide GMP services from pre-IND to post-marketed drug products, ensuring high-quality support throughout the drug development lifecycle.

  • Menadiona Pharma is a Spain-based CDMO specializing in small molecule API development and manufacturing, with capabilities spanning process development, scale-up, and cGMP production. The company focuses on custom synthesis of high-value, low- to mid-volume APIs, supporting pharmaceutical partners from development through commercial supply.

  • Moehs Group is a European API manufacturer and CDMO specializing in small-molecule active pharmaceutical ingredients, advanced intermediates, and fine chemicals. With more than 50 years of experience, the company supports pharmaceutical partners from development through commercial production, offering custom synthesis, process development, scale-up, analytical services, pilot-scale manufacturing, and cGMP API production.

  • Over its 35 year history, Moravek Biochemicals & Radiochemicals has successfully completed over 2,000 custom carbon-14 radiolabeling projects, with a 99% rate of success. Custom synthesis is carried out by an exceptionally capable team including 9 Ph.D. and 7 M.Sc. radiochemists.

  • Morepen Laboratories is a leading Indian pharmaceutical company specializing in the production of Active Pharmaceutical Ingredients (APIs), finished formulations, and diagnostics. With decades of industry experience, Morepen supplies high-quality APIs to top global pharmaceutical companies across more than 80 countries.

  • We provide solutions across the full range of the pharmaceutical industry’s chemistry requirements, from the synthesis of library compounds to supplying NCEs and advanced intermediates at various stages in the clinical life-cycle, as well as commercial launch.

  • NFIL USA is the North American arm of Navin Fluorine International Limited (NFIL), a global leader in specialty fluorochemicals. With a strong legacy in fluorination chemistry, NFIL USA supports pharmaceutical and agrochemical clients with custom synthesis, CDMO services, and high-performance fluorinated intermediates.

  • Pace Life Sciences is a full-service Contract Development and Manufacturing Organization (CDMO) offering integrated solutions from early-phase development through commercial manufacturing. With a focus on quality, speed, and flexibility, Pace supports pharmaceutical and biopharmaceutical clients in bringing products to market efficiently and safely.

  • Piramal Pharma Solutions is a Contract Development and Manufacturing Organization offering end-to-end development and manufacturing solutions across the drug life cycle. From 15 sites across North America, Europe, and India, we have the capacity, capability, and expertise to deliver whatever you need in the areas of drug substance and drug product.

  • PMC Isochem is a France-based CDMO specializing in the development and cGMP manufacturing of APIs, intermediates, and functional excipients. With over 40 years of experience and three FDA-audited sites near Paris, we serve global pharma clients across therapeutic areas including oncology, neurology, and infectious diseases.

  • Porton Pharma Solutions is a global company with over 4,200 employees and R&D and GMP-compliant manufacturing facilities across the US, EU, and China. It provides customer-centric, innovative, and reliable CDMO solutions for Small Molecules, Tides, Biologics and Conjugates (such as ADCs, AOCs, PDCs, RDCs, etc.), as well as Advanced Therapy Medicinal Products, from pre-clinical to commercial stages.

    Visit Website

  • Portrett Pharmaceuticals is a U.S.-based CDMO focused on drug product development and manufacturing, with particular strength in oral solid dosage forms and early-phase clinical supply. The company supports pharmaceutical and biotech partners from preformulation and formulation development through GMP manufacturing, offering services such as process optimization, scale-up, and analytical support.

  • PROCOS is an Italian-based company that is wholly owned subsidiary of CBC Co Ltd Group, founded in 1945, producing Active Ingredients and intermediates for the pharmaceutical market, in the Generic and custom manufacturing field. Company’s core know-how is high pressure technology- catalytic hydrogenations, carboxylations, reductive aminations and cryogenic reaction. Manufacturing and scaling up process are performed according to full cGMP.

    Visit Website

  • Rottendorf Pharma is a leading CDMO focused on oral solid dosage forms. The company offers end-to-end services including formulation and process development, scale-up, clinical and commercial manufacturing, analytical development, and packaging.

  • Sai Life Sciences is a global CRO-CDMO delivering discovery, development, and manufacturing solutions for small molecule APIs.
    Enabling speed and science for pharma innovators worldwide.

  • A leading contract service organization for over 40 years, SGS provides best-in-class services to support drug development from molecule to market, helping clients deliver high-quality, safe, and effective medicines to patients.

  • SK Pharmteco is a global CDMO providing end-to-end development and manufacturing services for small molecule APIs, intermediates, and advanced therapies. Formed through the integration of AMPAC Fine Chemicals, SK Biotek Korea, SK Biotek Ireland, and Yposkesi, the company combines deep technical expertise with a global footprint.

  • Launched over 40 years ago, Speciality Chemicals Magazine is the leading publication dedicated to the fine and speciality chemicals industry. Our mission is to provide readers with the latest news and developments on business, markets, and technology.

  • Sterling Pharma Solutions is a global contract development and manufacturing organisation with world-class facilities in the UK and US. Combining a full-service offering with expert knowledge and technical agility to offer API development and cGMP contract manufacturing capabilities, the team can support projects through the entire product lifecycle from grams to tonnes.

  • Suanfarma specializes in small molecule API development and manufacturing, with strong capabilities in complex chemistry and high-potency compounds. The Spanish company supports partners from early development through commercial production, offering process development, scale-up, and cGMP manufacturing across a network of European facilities.

  • At Sygnature Discovery, we create exceptional scientific outcomes for our customers who bring life-changing medicines to patients, and for our people who make this possible. We’re 700+ scientists from over 50 countries, working as one across Europe and North America. With no competing internal programs, we offer total confidentiality and commitment.

  • Established in 1994 as a subsidiary of Biocon Limited, Syngene is a leading custom research and manufacturing organization supporting R&D programs from lead generation to clinical supplies. With expertise in integrated drug discovery and development, we offer services in medicinal chemistry, biology, toxicology, custom synthesis, and cGMP manufacturing.

  • TC Scientific Inc. is a Canadian CRO based in Edmonton, Canada. We specialize in providing custom synthesis of impurities, advanced intermediates, final compounds and reference compounds ranging from milligrams to kilograms in scale. We pride ourselves in providing high quality services – delivered quickly and at reasonable prices. Working with us also ensures that your IP is in safe hands.

    Visit Website

  • The focus of the company is on helping the biotech, pharmaceutical, generic, and chemical industry to develop scalable, practical, robust and economically feasible syntheses for supporting small molecule business.

  • Established in 2008, Viva Biotech (01873.HK) provides integrated drug discovery and manufacturing services from early-stage R&D to commercial production. Leveraging expert teams and advanced technology platforms, we support small molecules, biologics, and PPO (peptide, protein, and oligonucleotide) programs.

  • Wilmington PharmaTech is a full-service CRO serving pharmaceutical and biotechnology companies in five major areas, including cGMP synthesis, Salt and Polymorph Studies, FTE Research, Analytical Services, and Bulk Intermediate Synthesis.

  • YAMASA Corporation is a Japan-based pharmaceutical manufacturer specializing in nucleic acid–related active pharmaceutical ingredients (APIs), intermediates, and fine chemicals for the global pharmaceutical industry. With more than four decades of experience in cGMP API manufacturing, the company supports pharmaceutical and biotech partners from early-stage process development through commercial-scale production. YAMASA is particularly recognized for its expertise in nucleotide and nucleoside chemistry, highly specialized small molecule synthesis, and complex multi-step manufacturing processes requiring strict quality and regulatory compliance.

  • WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform.

  • YUHAN – A Value-Adding Partner For Your Tight Timeline
    YUHAN, a pharmaceutical company with an 89-year history in Korea, provides contract services for research, development, and manufacturing of APIs and intermediates. Offering one-stop services from lab-scale process development through commercial manufacturing.

  • Zach System | Zambon is a CDMO company located in Avrille, France specialized in the production in exclusivity of Active Pharmaceutical Ingredients (API) from Phase I/II to Commercial quantities. Our DNA is to accompany our customers all along the process development activity, the scale-up phases, the validation of processes and method of analysis and the DMF filing.